Translational Development Acquisition Corp. (TDACU) Stock Analysis

Financial Services

Translational Development Acquisition Corp.

$17.29

+$6.85 (+65.61%)

Last Updated: May 26, 2026

Price History

Related Shell Companies Stocks

Twenty One Capital, Inc.

$2.49B

Churchill Capital Corp X

$711.00M

Drugs Made In America Acquisition II Corp.

$641.46M

Bain Capital GSS Investment Corp.

$595.68M

EQV Ventures Acquisition Corp. II

$594.41M

Cantor Equity Partners IV, Inc.

$591.50M

View all Shell Companies stocks →

Popular Financial Services Stocks

Berkshire Hathaway Inc.

$1.38T

Berkshire Hathaway Inc.

$1.04T

Berkshire Hathaway Inc.

$1.04T

JPMorgan Chase & Co.

$821.91B

Visa Inc.

$620.88B

View all Financial Services stocks →

About Translational Development Acquisition Corp.

Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

Visit website →

Key Statistics

Market Cap: N/A
P/E Ratio: N/A
52-Week High: $17.29
52-Week Low: $10.27
Avg Volume: 133

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Industry: Shell Companies
Exchange: NASDAQ
Country: United States